Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Catheter Equipment

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1788305

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1788305

Pulmonary Stents

PUBLISHED:
PAGES: 170 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Pulmonary Stents Market to Reach US$331.1 Million by 2030

The global market for Pulmonary Stents estimated at US$248.8 Million in the year 2024, is expected to reach US$331.1 Million by 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. Self-expandable Stents, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$221.5 Million by the end of the analysis period. Growth in the Balloon-expandable Stents segment is estimated at 3.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$65.4 Million While China is Forecast to Grow at 4.7% CAGR

The Pulmonary Stents market in the U.S. is estimated at US$65.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$53.2 Million by the year 2030 trailing a CAGR of 4.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.6% and 4.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Pulmonary Stents Market - Key Trends & Drivers Summarized

Why Are Pulmonary Stents Becoming Essential in Respiratory Medicine?

Pulmonary stents play a crucial role in managing airway obstruction caused by conditions such as tracheobronchial stenosis, lung cancer, chronic obstructive pulmonary disease (COPD), and post-surgical complications. These stents help maintain airway patency, allowing patients to breathe more easily and improving overall quality of life. As the prevalence of respiratory disorders continues to rise due to environmental pollution, smoking, and aging populations, the demand for pulmonary stents has grown significantly. Unlike invasive surgical procedures, stent placement via bronchoscopy offers a minimally invasive solution, reducing patient recovery time and hospital stays. The increasing preference for non-surgical interventions in respiratory care has driven advancements in pulmonary stent technology, making them more effective, durable, and biocompatible. Healthcare providers are increasingly incorporating pulmonary stents into treatment protocols to manage complex airway diseases, leading to expanded adoption across hospitals and specialty clinics worldwide.

How Are Technological Advancements Improving Pulmonary Stent Performance?

Recent innovations in pulmonary stent design and materials have significantly enhanced their clinical efficacy and patient outcomes. Traditional metal and silicone stents have been refined to minimize migration risks and improve long-term stability within the airways. The introduction of self-expanding stents, which adapt to airway contours and reduce the need for frequent repositioning, has improved procedural success rates. Furthermore, drug-eluting pulmonary stents, coated with anti-inflammatory or anti-proliferative agents, are being developed to prevent restenosis and reduce the likelihood of repeat interventions. Bioresorbable stents, which gradually dissolve over time, are emerging as a promising alternative for temporary airway support, eliminating the need for stent removal procedures. Enhanced imaging technologies such as high-resolution CT scans and guided bronchoscopy have also improved the precision of stent placement, reducing complications and optimizing treatment outcomes. As research continues to focus on improving stent flexibility, biocompatibility, and long-term efficacy, the next generation of pulmonary stents is expected to set new standards in respiratory medicine.

What Factors Are Driving the Adoption of Pulmonary Stents?

The increasing prevalence of lung diseases, coupled with rising awareness about minimally invasive treatment options, has fueled the demand for pulmonary stents. Patients and healthcare providers are favoring bronchoscopic stenting over traditional open surgeries due to lower risks, faster recovery times, and improved patient comfort. The rising incidence of lung cancer, particularly in aging populations, has further accelerated the need for airway management solutions, with pulmonary stents being widely used for palliative care in advanced-stage cancer patients. Additionally, the growing number of COPD cases worldwide, driven by air pollution and smoking habits, has led to increased stent placements to manage airway obstruction effectively. Technological advancements in stent manufacturing, such as hybrid designs that combine the benefits of metal and silicone, are also contributing to market growth by offering enhanced durability and functionality. The availability of reimbursement policies for pulmonary interventions in many developed countries is further encouraging hospitals and specialty clinics to adopt these devices for airway management.

What Are the Key Drivers Fueling Growth in the Pulmonary Stents Market?

The growth in the global pulmonary stents market is driven by several key factors, including the rising incidence of chronic respiratory diseases, advancements in stent design and materials, and the increasing adoption of minimally invasive airway management techniques. The expansion of healthcare infrastructure, particularly in emerging markets, is improving access to advanced respiratory treatments, boosting demand for pulmonary stents. The integration of AI-powered imaging and robotic-assisted bronchoscopy is also enhancing procedural accuracy, making stent placement more effective and reducing complication rates. Furthermore, the growing investment in respiratory care by healthcare providers, research institutions, and medical device manufacturers is accelerating innovation in pulmonary stent technology. Regulatory approvals for next-generation stents, along with increasing collaborations between medical device companies and healthcare organizations, are further driving market expansion. As the demand for effective airway management solutions continues to grow, the pulmonary stents market is poised for sustained development, with ongoing advancements shaping the future of respiratory care.

SCOPE OF STUDY:

The report analyzes the Pulmonary Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Self-expandable Stents, Balloon-expandable Stents); Material (Metal, Silicon, Hybrid); Type (Tracheobronchial Stents, Laryngeal Stents)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Abbott
  • B. Braun Melsungen AG
  • Bayer AG
  • Bess Medizintechnik GmbH
  • Biosensors International Group, Ltd.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc. (Cordis)
  • Cook Group
  • E. Benson Hood Laboratories, Inc.
  • EFER ENDOSCOPY
  • ENDO-FLEX GmbH
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Lepu Medical Technology
  • M.I. Tech
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Micro-Tech (Nanjing) Co., Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP32727

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Pulmonary Stents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Tracheobronchial Obstructions and Airway Stenosis Throws the Spotlight on Pulmonary Stent Utilization
    • Expansion of Interventional Pulmonology and Minimally Invasive Airway Management Drives Adoption of Pulmonary Stents
    • Increasing Prevalence of COPD, Lung Cancer, and Post-Intubation Stenosis Strengthens Business Case for Airway Stenting
    • Advancements in Stent Design, Flexibility, and Radial Force Propel Innovation in Customized Pulmonary Stents
    • Surge in Geriatric Population and Age-Related Respiratory Disorders Drives Demand for Long-Term Airway Patency Solutions
    • Development of Drug-Eluting and Bioabsorbable Pulmonary Stents Expands the Therapeutic Scope for Chronic Pulmonary Conditions
    • Rising Adoption of 3D Printing and Patient-Specific Stent Models Enhances Procedural Precision and Clinical Outcomes
    • Integration of Bronchoscopic Navigation and Imaging Systems Improves Placement Accuracy and Procedural Safety
    • Growing Use of Temporary and Removable Silicone Stents Spurs Preference for Less Invasive and Reversible Airway Interventions
    • Regulatory Approvals and Reimbursement Policies Supporting Interventional Pulmonary Devices Propel Market Penetration
    • Increased Focus on Airway Rescue and Palliative Interventions in Advanced-Stage Oncology Boosts Pulmonary Stent Procedures
    • Emergence of Customized Hybrid Stents Combining Metal and Polymer Components Enhances Functional Performance
    • Collaborations Between Pulmonologists and Thoracic Surgeons Drive Adoption of Multidisciplinary Airway Management Approaches
    • Expansion of Specialized Centers for Complex Airway Disorders Spurs Training and Procedural Volumes Globally
    • Surging Demand for Pediatric Airway Stents Creates Opportunities for Miniaturized and Growth-Adaptive Device Designs
    • Focus on Reducing Granulation Tissue Formation and Migration Complications Drives Next-Generation Stent Development
    • Growth of Ambulatory Bronchoscopy Services Accelerates Use of Pulmonary Stents in Outpatient Settings
    • Rising Use of Pulmonary Stents in Emergency Airway Obstruction Scenarios Fuels Demand for Rapid-Deployment Systems
    • Investment in Clinical Trials and Real-World Evidence Collection Strengthens Regulatory Support and Market Confidence
    • Integration of Pulmonary Stents with Adjunctive Therapies Like Radiation and Chemotherapy Expands Multimodal Treatment Models
    • Expansion into Emerging Markets with Rising Respiratory Disease Burden Sustains Global Demand for Pulmonary Stenting Solutions
    • Focus on Sustainable Manufacturing and Biocompatible Materials Supports Eco-Efficient and Patient-Centric Innovation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Pulmonary Stents Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Pulmonary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Pulmonary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Self-expandable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Self-expandable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Balloon-expandable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Balloon-expandable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Metal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Metal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Silicon by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Silicon by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Hybrid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Hybrid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Tracheobronchial Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Tracheobronchial Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Laryngeal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Laryngeal Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 18: USA Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 19: USA 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • CANADA
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Canada 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • JAPAN
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Japan 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • CHINA
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 36: China Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: China 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 40: China Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • EUROPE
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 43: Europe 6-Year Perspective for Pulmonary Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • FRANCE
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 52: France Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: France 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 54: France Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • GERMANY
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Germany 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Italy 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • UNITED KINGDOM
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 70: UK Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: UK 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 72: UK Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Rest of Europe 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Asia-Pacific 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 86: Rest of World Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of World 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of World 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!